Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lopinavir”

220 trials

Showing 20 of 220 results

Post-approval studies (Phase 4)Ended earlyNCT00765154
What this trial is testing

NNRTI/PI Toxicity Switch to Darunavir Study

Who this might be right for
HIV
St Stephens Aids Trust 12
Post-approval studies (Phase 4)Ended earlyNCT00414284
What this trial is testing

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

Who this might be right for
HIV Infections
Community Research Initiative of New England
Post-approval studies (Phase 4)UnknownNCT04779047
What this trial is testing

Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.

Who this might be right for
Covid19Pneumonia
October 6 University 150
Large-scale testing (Phase 3)Study completedNCT00050895
What this trial is testing

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 775
Post-approval studies (Phase 4)UnknownNCT04350671
What this trial is testing

Interferon Beta 1a in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Early research (Phase 1)Study completedNCT00867152
What this trial is testing

GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir

Who this might be right for
Healthy Volunteer
ViiV Healthcare 17
Large-scale testing (Phase 3)Study completedNCT01002898
What this trial is testing

Ritonavir-boosted Lopinavir Monotherapy

Who this might be right for
HIV
Bamrasnaradura Infectious Diseases Institute 40
Post-approval studies (Phase 4)Study completedNCT00810108
What this trial is testing

Lopinavir/Ritonavir (Kaletra) PK in Children

Who this might be right for
HIV/AIDS TreatmentHIV Infections
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 12
Testing effectiveness (Phase 2)Study completedNCT00116636
What this trial is testing

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

Who this might be right for
HIV Infections
Therapeutic Concepts 40
Post-approval studies (Phase 4)Study completedNCT01818258
What this trial is testing

IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children

Who this might be right for
HIV PositiveMalnourished
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 52
Post-approval studies (Phase 4)Study completedNCT00771498
What this trial is testing

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Who this might be right for
HIV InfectionTuberculosis
Oswaldo Cruz Foundation 30
Large-scale testing (Phase 3)Ended earlyNCT00144833
What this trial is testing

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

Who this might be right for
HIV-1
GlaxoSmithKline 150
Post-approval studies (Phase 4)Study completedNCT00335686
What this trial is testing

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 67
Large-scale testing (Phase 3)Study completedNCT00358917
What this trial is testing

Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects

Who this might be right for
Human Immunodeficiency Virus Infections
Abbott 599
Post-approval studies (Phase 4)Study completedNCT00626301
What this trial is testing

Lopinavir/Ritonavir Monotherapy in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 40
Not applicableStudy completedNCT00102986
What this trial is testing

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 116
Post-approval studies (Phase 4)Study completedNCT00234975
What this trial is testing

Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score

Who this might be right for
HIV Infection
AbbVie (prior sponsor, Abbott) 86
Early research (Phase 1)Study completedNCT01571414
What this trial is testing

Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 52
Large-scale testing (Phase 3)Study completedNCT02150993
What this trial is testing

First-Line Treatment for HIV-2

Who this might be right for
HIV-2 Infection
ANRS, Emerging Infectious Diseases 210
Post-approval studies (Phase 4)Ended earlyNCT00100984
What this trial is testing

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

Who this might be right for
HIV Infection
Hoffmann-La Roche 8
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation